Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery
- 1 September 2016
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 111, 34-42
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- CDK‐mediated activation of the SCFFBXO28 ubiquitin ligase promotes MYC‐driven transcription and tumourigenesis and predicts poor survival in breast cancerEMBO Molecular Medicine, 2013
- The Novel Ubiquitin Ligase Complex, SCFFbxw4, Interacts with the COP9 Signalosome in an F-Box Dependent Manner, Is Mutated, Lost and Under-Expressed in Human CancersPLOS ONE, 2013
- Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligasesCell Research, 2013
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destructionNature, 2011
- RBX1 (RING Box Protein 1) E3 Ubiquitin Ligase Is Required for Genomic Integrity by Modulating DNA Replication Licensing ProteinsJournal of Biological Chemistry, 2011
- Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancerNature Reviews Cancer, 2008
- FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationNature Reviews Cancer, 2008
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaNew England Journal of Medicine, 2005
- Function and regulation of cullin–RING ubiquitin ligasesNature Reviews Molecular Cell Biology, 2005
- Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complexNature, 2002